MRTX-1257-d6
Modify Date: 2024-04-09 23:53:10
MRTX-1257-d6 structure
|
Common Name | MRTX-1257-d6 | ||
|---|---|---|---|---|
| CAS Number | 2639608-44-7 | Molecular Weight | 571.75 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C33H33D6N7O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MRTX-1257-d6MRTX-1257-d6 is the deuterium labeled MRTX-1257 (HY-114436). MRTX-1257 is a selective, irreversible, covalent and orally active KRAS G12C inhibitor, with an IC50 of 900 pM for KRAS dependent ERK phosphorylation in H358 cells[1][2]. |
| Name | MRTX-1257-d6 |
|---|
| Description | MRTX-1257-d6 is the deuterium labeled MRTX-1257 (HY-114436). MRTX-1257 is a selective, irreversible, covalent and orally active KRAS G12C inhibitor, with an IC50 of 900 pM for KRAS dependent ERK phosphorylation in H358 cells[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。 |
| References |
| Molecular Formula | C33H33D6N7O2 |
|---|---|
| Molecular Weight | 571.75 |